STEPHEN DAVIS

Insider Reports History

Location
San Diego, CA
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by STEPHEN DAVIS:

Company Role Class Num Shares Value Price $ Report Date Ownership
ACADIA PHARMACEUTICALS INC CEO, Director Common Stock 186,555 $2,850,560 $15.28 19 Aug 2024 Direct
ACADIA PHARMACEUTICALS INC CEO, Director Restricted Stock Units 67,173 $1,200,382 $17.87 01 May 2024 Direct
HERON THERAPEUTICS, INC. /DE/ Director Stock Option (Right to Buy) 77,160 $137,345 $1.78 16 Dec 2022 Direct
HERON THERAPEUTICS, INC. /DE/ Director Common Stock 52,032 $111,869 $2.15 16 Dec 2022 Direct
ACADIA PHARMACEUTICALS INC CEO, Director Stock Option (Right to Buy) 286,451 25 Mar 2024 Direct
BELLICUM PHARMACEUTICALS, INC Director Common Stock 136,854 03 Jan 2023 Direct

Insider Reports Filed by STEPHEN DAVIS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACAD ACADIA PHARMACEUTICALS INC 16 Aug 2024 3 -$485,094 4 CEO, Director 20 Aug 2024, 18:40
ACAD ACADIA PHARMACEUTICALS INC 01 May 2024 3 -$193,573 4 CEO, Director 03 May 2024, 18:00
ACAD ACADIA PHARMACEUTICALS INC 05 Apr 2024 6 -$474,877 4 CEO, Director 09 Apr 2024, 18:00
ACAD ACADIA PHARMACEUTICALS INC 25 Mar 2024 3 -$317,081 4 CEO, Director 27 Mar 2024, 19:58
ACAD ACADIA PHARMACEUTICALS INC 23 Feb 2024 3 -$137,585 4 CEO, Director 27 Feb 2024, 18:02
ACAD ACADIA PHARMACEUTICALS INC 06 Jan 2024 3 -$111,811 4 CEO, Director 09 Jan 2024, 18:00
ACAD ACADIA PHARMACEUTICALS INC 05 Oct 2023 3 -$1,132,323 4 CEO, Director 06 Oct 2023, 21:59
ACAD ACADIA PHARMACEUTICALS INC 14 Jul 2023 3 -$927,350 4 CEO, Director 18 Jul 2023, 18:00
ACAD ACADIA PHARMACEUTICALS INC 11 Jul 2023 2 -$1,792,899 4 CEO, Director 13 Jul 2023, 20:27
ACAD ACADIA PHARMACEUTICALS INC 01 May 2023 2 $0 4 CEO, Director 03 May 2023, 21:16
ACAD ACADIA PHARMACEUTICALS INC 29 Apr 2023 3 -$165,331 4 CEO, Director 02 May 2023, 19:02
ACAD ACADIA PHARMACEUTICALS INC 05 Apr 2023 3 -$155,849 4 CEO, Director 07 Apr 2023, 20:34
ACAD ACADIA PHARMACEUTICALS INC 23 Feb 2023 3 -$72,322 4 CEO, Director 27 Feb 2023, 20:00
ACAD ACADIA PHARMACEUTICALS INC 06 Jan 2023 3 -$66,877 4 CEO, Director 10 Jan 2023, 19:38
BLCM BELLICUM PHARMACEUTICALS, INC 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 12:12
HRTX HERON THERAPEUTICS, INC. /DE/ 16 Dec 2022 2 $0 4 Director 20 Dec 2022, 16:19
ACAD ACADIA PHARMACEUTICALS INC 15 Oct 2022 3 -$44,331 4 CEO, Director 18 Oct 2022, 21:16
BLCM BELLICUM PHARMACEUTICALS, INC 01 Sep 2022 1 $0 4 Director 02 Sep 2022, 10:30
BLCM BELLICUM PHARMACEUTICALS, INC 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 14:49
ACAD ACADIA PHARMACEUTICALS INC 29 Apr 2022 3 -$99,691 4 CEO, Director 03 May 2022, 20:58
ACAD ACADIA PHARMACEUTICALS INC 05 Apr 2022 3 $0 4 CEO, Director 07 Apr 2022, 18:39
ACAD ACADIA PHARMACEUTICALS INC 23 Feb 2022 3 -$93,486 4 CEO, Director 25 Feb 2022, 16:40
ACAD ACADIA PHARMACEUTICALS INC 06 Jan 2022 3 -$85,700 4 CEO, Director 10 Jan 2022, 17:22
BLCM BELLICUM PHARMACEUTICALS, INC 04 Jan 2022 2 $0 4 Director 06 Jan 2022, 08:31
HRTX HERON THERAPEUTICS, INC. /DE/ 22 Dec 2021 2 $0 4 Director 23 Dec 2021, 17:55
ACAD ACADIA PHARMACEUTICALS INC 15 Oct 2021 3 -$51,586 4 CEO, Director 19 Oct 2021, 17:30
BLCM BELLICUM PHARMACEUTICALS, INC 15 Jun 2021 1 $0 4 Director 07 Jul 2021, 20:25